Caris Life Sciences, Inc. (CAI)
Nasdaq: CAI · Services-Medical Laboratories · Irving, TX · filing with the SEC since 2024
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 3, 2026 | · | · |
| Revenue | 812,033 | 412,260 | 306,128 |
| Research and development | 101,584 | 113,916 | 116,883 |
| Sales and marketing | 167,506 | 152,602 | 142,925 |
| General and administrative | 224,965 | 169,386 | 149,053 |
| Total costs and expenses | 766,920 | 669,382 | 625,679 |
| Operating income | 45,113 | -257,122 | -319,551 |
| Interest expense | 56,853 | 50,025 | 31,610 |
| Interest and investment income | 16,497 | 7,122 | 11,258 |
| Other income (expense), net | -20,560 | -349 | -12,606 |
| Total non-operating income (expense) | -113,201 | -24,768 | -21,864 |
| Income before income taxes | -68,088 | -281,890 | -341,415 |
| Income tax expense | 0 | 0 | 0 |
| Net income | -68,088 | -281,890 | -341,415 |
| Net income to common shareholders | -537,957 | -378,257 | -462,527 |
| Earnings per share, basic | -3.22 | -10.66 | -13.24 |
| Earnings per share, diluted | -3.22 | -10.66 | -13.24 |
| Weighted average shares, basic | 167,205,616 | 35,496,832 | 34,942,691 |
| Weighted average shares, diluted | 167,205,616 | 35,496,832 | 34,942,691 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding